Literature DB >> 15479852

Genetic interactions between hepatitis C virus replicons.

Matthew J Evans1, Charles M Rice, Stephen P Goff.   

Abstract

To investigate interactions between hepatitis C virus (HCV) RNA replication complexes, a system was developed to simultaneously select different HCV subgenomic replicons within the same cell. Transcomplementation of defective replicons was not observed, suggesting an isolated and independent nature of the HCV RNA replication complex. In contrast, a high level of competition between replicons was observed, such that the presence and increased fitness of one replicon reduced the capacity of a second one to stably replicate. These results suggest that at least one factor in Huh7 cells required for HCV RNA replication is limiting and saturable.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479852      PMCID: PMC523274          DOI: 10.1128/JVI.78.21.12085-12089.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  cis- and trans-acting elements in flavivirus RNA replication.

Authors:  A A Khromykh; P L Sedlak; E G Westaway
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly.

Authors:  Wen Jun Liu; Petra L Sedlak; Natasha Kondratieva; Alexander A Khromykh
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase.

Authors:  A A Khromykh; P L Sedlak; K J Guyatt; R A Hall; E G Westaway
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Genetic analysis of the pestivirus nonstructural coding region: defects in the NS5A unit can be complemented in trans.

Authors:  C W Grassmann; O Isken; N Tautz; S E Behrens
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  trans-Complementation analysis of the flavivirus Kunjin ns5 gene reveals an essential role for translation of its N-terminal half in RNA replication.

Authors:  A A Khromykh; P L Sedlak; E G Westaway
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

6.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations.

Authors:  N Krieger; V Lohmann; R Bartenschlager
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

9.  A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg.

Authors:  Olga Kalinina; Helene Norder; Sergey Mukomolov; Lars O Magnius
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 10.  Recent advances in the molecular biology of hepatitis C virus.

Authors:  S Rosenberg
Journal:  J Mol Biol       Date:  2001-10-26       Impact factor: 5.469

View more
  22 in total

Review 1.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 2.  New therapeutic opportunities for hepatitis C based on small RNA.

Authors:  Qiu-Wei Pan; Scot D Henry; Bob J Scholte; Hugo W Tilanus; Harry L A Janssen; Luc J W van der Laan
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

3.  Hepatitis C virus co-opts Ras-GTPase-activating protein-binding protein 1 for its genome replication.

Authors:  Zhigang Yi; Tingting Pan; Xianfang Wu; Wuhui Song; Shanshan Wang; Yan Xu; Charles M Rice; Margaret R Macdonald; Zhenghong Yuan
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

4.  Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase.

Authors:  Angela M I Lam; David N Frick
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes.

Authors:  Torsten Schaller; Nicole Appel; George Koutsoudakis; Stephanie Kallis; Volker Lohmann; Thomas Pietschmann; Ralf Bartenschlager
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

6.  Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.

Authors:  Brian Webster; Silke Wissing; Eva Herker; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

7.  High levels of subgenomic HCV plasma RNA in immunosilent infections.

Authors:  Flavien Bernardin; Susan L Stramer; Barbara Rehermann; Kimberly Page-Shafer; Stewart Cooper; David R Bangsberg; Judith Hahn; Leslie Tobler; Michael Busch; Eric Delwart
Journal:  Virology       Date:  2007-05-09       Impact factor: 3.616

8.  Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles.

Authors:  Eike Steinmann; Christiane Brohm; Stephanie Kallis; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

9.  Cochaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway.

Authors:  Shuhei Taguwa; Hiroto Kambara; Hiroko Omori; Hideki Tani; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Tamotsu Yoshimori; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

Review 10.  Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases.

Authors:  Po-Yuan Ke; Steve S-L Chen
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.